drugset / Trial / NCT00411879

Combined Vasopressin, Methylprednisolone, and Epinephrine for Inhospital Cardiac Arrest

NCT00411879

Phase 2 Completed 100 enrolled University of Athens
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A randomized controlled trial did not show benefit of vasopressin versus epinephrine in inhospital cardiac arrest. Preceding laboratory data suggest that combined vasopressin and epinephrine ensure long-term survival and neurologic recovery. Also, postresuscitation abnormalities mimic severe sepsis. The investigators hypothesized that combined vasopressin and epinephrine during cardiopulmonary resuscitation (CPR), and steroid supplementation during and after (when required) CPR may improve survival in cardiac arrest.

Timeline

Start
2006-06
Primary completion
2007-04
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified 40 mg Intravenous
Subject Vasopressin Peptide 20 iu Intravenous
Subject Vasopressin, Epinephrine, and Steroids Unknown 300 mg
Background Epinephrine Other / unclassified 1 mg

Indications